Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study to Study the Clinical Response to ACT Fixed Dose Combination in 42 Days in Uncomplicated Malaria in Cameroon

NCT01845701 is registered in ClinicalTrials.gov with University of Yaounde 1 as lead sponsor.

NCT NCT01845701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01845701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study to Study the Clinical Response to ACT Fixed Dose Combination in 42 Days in Uncomplicated Malaria in Cameroon
Lead sponsor
University of Yaounde 1
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2010
Completion date
April 30, 2015
Enrollment
720 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria